The content on this site is intended for healthcare professionals only
EHA president-elect Prof Gribbin speaks with ecancer at EHA 23 about the development of EHA Topics in Focus, and the educational emphasis being placed on CAR-T cell immunotherapy.
He discusses the reasoning behind developing Topics in Focus from the conference, and the current state of access to the latest immunotherapies on an individual and national level.
Prof Gribbin emphasises the educational opportunities of EHA membership, meetings, and collaborations in developing leading haematological care.
For more on EHA Topics in Focus, watch our interview with current EHA president Prof Pieter Sonneveld.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Multiple myeloma in a resource constrained setting
Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems
Relapsed refractory multiple myeloma
